Your browser doesn't support javascript.
loading
Monitoring Patients With Eosinophilic Esophagitis in Routine Clinical Practice - International Expert Recommendations.
Arnim, Ulrike von; Biedermann, Luc; Aceves, Seema S; Bonis, Peter A; Collins, Margaret H; Dellon, Evan S; Furuta, Glenn T; Gonsalves, Nirmala; Gupta, Sandeep; Hirano, Ikuo; Lucendo, Alfredo J; Miehlke, Stephan; Oliva, Salvatore; Schlag, Christoph; Schoepfer, Alain; Straumann, Alex; Vieth, Michael; Bredenoord, Albert J.
Afiliación
  • Arnim UV; Department of Gastroenterology, Hepatology, and Infectious Diseases, University Hospital, Magdeburg, Germany. Electronic address: Ulrike.vonarnim@med.ovgu.de.
  • Biedermann L; Department of Gastroenterology and Hepatology, University Hospital Zürich, Zurich, Switzerland.
  • Aceves SS; Eosinophilic Gastrointestinal Disorders Clinic, Division of Allergy Immunology, Rady Children's Hospital, San Diego University of California, San Diego, California.
  • Bonis PA; Wolters Kluwer Health, Waltham, Massachusetts.
  • Collins MH; Division of Pathology and Laboratory Medicine, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio.
  • Dellon ES; Center for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
  • Furuta GT; Digestive Health Institute, Section of Pediatric Gastroenterology, Hepatology and Nutrition, Children's Hospital Colorado, Aurora, Colorado; Gastrointestinal Eosinophilic Diseases Program, Department of Pediatrics, Mucosal Inflammation Program, University of Colorado School of Medicine, Aurora, Colo
  • Gonsalves N; Division of Gastroenterology and Hepatology, Northwestern University - Feinberg School of Medicine, Chicago, Illinois.
  • Gupta S; Community Hospital Network, Division of Pediatric Gastroenterology/Hepatology/Nutrition, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, Indiana.
  • Hirano I; Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Lucendo AJ; Department of Gastroenterology, Hospital General de Tomelloso, Vereda de Socuéllamos s/n, Tomelloso, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain.
  • Miehlke S; Centre for Digestive Diseases, Internal Medicine Centre Eppendorf, Hamburg, Germany.
  • Oliva S; Pediatric Gastroenterology and Liver Unit, Maternal and Child Health Department, Sapienza - University of Rome, Rome, Italy.
  • Schlag C; Department of Gastroenterology and Hepatology, University Hospital Zürich, Zurich, Switzerland.
  • Schoepfer A; Division of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland.
  • Straumann A; Department of Gastroenterology and Hepatology, University Hospital Zürich, Zurich, Switzerland.
  • Vieth M; Institute of Pathology, Friedrich-Alexander-University Erlangen-Nuremberg, Klinikum Bayreuth, Bayreuth, Germany.
  • Bredenoord AJ; Department of Gastroenterology, Amsterdam University Medical Center, Netherlands.
Clin Gastroenterol Hepatol ; 21(10): 2526-2533, 2023 09.
Article en En | MEDLINE | ID: mdl-36572109
ABSTRACT
BACKGROUND &

AIMS:

There are no studies or recommendations on optimal monitoring strategies for patients with eosinophilic esophagitis (EoE). Our objective was to develop guidance on how to monitor patients with EoE in routine clinical practice, on the basis of available clinical evidence and expert opinion.

METHODS:

A multidisciplinary, international group of EoE experts identified the following important 3 questions during several consensus meetings why, by what means, and when to monitor patients with EoE. A steering committee was named, and 3 teams were formed to review literature and to formulate statements for each topic. In a Delphi survey, a level of agreement of ≥75% was defined as threshold value for acceptance. In a final conference, results were presented, critical points and comments on the statements were discussed, and statements were rephrased/rewritten if necessary.

RESULTS:

Eighteen EoE experts (14 adult and pediatric gastroenterologists, 2 pathologists and 2 allergists) with a median of 21.7 years in clinical practice, mostly academic or university-based, completed the Delphi survey, which included 11 statements and a proposed algorithm for monitoring patients with EoE. Each statement attained ≥75% agreement. Participants discussed and debated mostly about the statement concerning surveillance intervals for EoE patients with stable disease.

CONCLUSIONS:

It was concluded that effective maintenance treatment probably reduces the development of EoE complications, and regular, structured, and, under certain conditions, individualized clinical follow-up is recommended to assess disease activity while opening a window to monitoring side effects, adjusting therapy, and encouraging adherence to treatment. Follow-up should comprise symptom assessment and periodic or repeated endoscopy with histological assessment in specific EoE settings.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Asunto principal: Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / Esofagitis Eosinofílica Tipo de estudio: Guideline / Qualitative_research Límite: Adult / Child / Humans Idioma: En Revista: Clin Gastroenterol Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Asunto principal: Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / Esofagitis Eosinofílica Tipo de estudio: Guideline / Qualitative_research Límite: Adult / Child / Humans Idioma: En Revista: Clin Gastroenterol Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2023 Tipo del documento: Article